Skip to content
Home / Companies / RCKT RCK
ROCKET PHARMACEUTICALS, INC. (RCKT) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest RCKT Insider Trades
About ROCKET PHARMACEUTICALS, INC. (RCKT) Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Headquarters NEW YORK, NY
Employees 202
Listed 2015
Exchange XNAS https://www.rocketpharma.com SEC filings for RCKT on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 6 50,613 $176K Grant or award 14 720,143 Other acquisition / disposition 1 150,000
RCKT Insider Transactions (Form 4) 56 91 Form 4 filings on record, the earliest from Oct 29, 2024, newest first. Filing history page 1 of 3.
Date Insider Transaction Security Shares Price Value Aug 18, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 631
Recent RCKT Form 8-K Filings 5
Recent RCKT Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 18, 2026 Wilson Martin Officer 631 $2K View on EDGAR Aug 18, 2026 Militello John Former Officer
RCKT Insider Trading - FAQ
What is the latest insider trade for RCKT? ROCKET PHARMACEUTICALS, INC. (RCKT) had 14 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for RCKT runs to 91 Form 4 filings, the earliest from 2024-10-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RCKT stock? No insider purchases of RCKT were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling RCKT stock? 6 insider sales of RCKT were filed in the last 90 days, totaling $176K.
Where can I see RCKT SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks RCKT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RCKT insider buys? Create a free InsiderAlpha account and press Watch on this page to add RCKT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track RCKT insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $8K
GS Gaurav Shah - Officer Open-market sale $10K
Aug 13, 2026
GS Gaurav Shah - Officer Open-market sale $172K
May 21, 2026
Market cap $423.73M
P/E ratio -
Dividend yield -
Average volume 2.19M
52 week high $5.45
52 week low $2.53
Today's high $3.99
Today's low $3.53
Open $3.61
Volume 3.45M
Previous close $3.62
Shares outstanding 109.77M Market cap
$423.73M
202 employees
RCKT Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 6 sales totaling $176K.
Most-Active RCKT Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 18, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 2,293 $3.38 $8K
Aug 13, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 2,837 $3.38 $10K
Aug 13, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 3,493 $3.38 $12K
Jun 18, 2026 RW Roderick Wong Grant or award Common Stock 27,832 $0.00 -
Jun 18, 2026 RW Roderick Wong Grant or award Stock Option (Right to Buy) 78,960 $0.00 -
Jun 18, 2026 PF Peter Fong Grant or award Common Stock 22,862 $0.00 -
Jun 18, 2026 PF Peter Fong Grant or award Stock Option (Right to Buy) 64,860 $0.00 -
Jun 18, 2026 MD Mikael Dolsten Grant or award Stock Option (Right to Buy) 64,860 $0.00 -
Jun 18, 2026 CB Carsten Boess Grant or award Common Stock 22,862 $0.00 -
Jun 18, 2026 CB Carsten Boess Grant or award Stock Option (Right to Buy) 64,860 $0.00 -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 10,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 10,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 10,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 20,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 20,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 2,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 18,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 18,000 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 27,003 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 28,910 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 49,798 - -
May 26, 2026 JM John Militello - Officer Derivative Stock Option (Right to Buy) 24,545 - -
May 26, 2026 JM John Militello - Officer Grant or award Stock Option (Right to Buy) 51,509 - -
May 26, 2026 JM John Militello - Officer Grant or award Stock Option (Right to Buy) 15,002 - -
May 26, 2026 JM John Militello - Officer Grant or award Stock Option (Right to Buy) 16,061 - -
May 26, 2026 JM John Militello - Officer Grant or award Stock Option (Right to Buy) 24,899 - -
May 26, 2026 JM John Militello - Officer Grant or award Stock Option (Right to Buy) 9,091 - -
May 21, 2026 GS Gaurav Shah - Officer Option exercise Common Stock 76,490 $1.69 $129K
May 21, 2026 GS Gaurav Shah - Officer Option exercise Stock Option (Right to Buy) 76,490 $1.69 $129K
May 21, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 55,684 $3.09 $172K
May 19, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 2,409 $3.01 $7K
May 19, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 662 $3.01 $2K
May 19, 2026 JM John Militello - Officer Open-market sale Common Stock 384 $3.01 $1K
May 13, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 3,361 $3.61 $12K
May 13, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 2,728 $3.61 $10K
May 13, 2026 JM John Militello - Officer Open-market sale Common Stock 855 $3.61 $3K
Feb 18, 2026 JM John Militello - Officer Open-market sale Common Stock 1,157 $3.34 $4K
Feb 18, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 5,990 $3.34 $20K
Feb 18, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 1,376 $3.34 $5K
Feb 13, 2026 MW Martin Wilson - Officer Open-market sale Common Stock 12,253 $3.31 $41K
Feb 13, 2026 JM John Militello - Officer Open-market sale Common Stock 3,726 $3.31 $12K
Feb 13, 2026 GS Gaurav Shah - Officer Open-market sale Common Stock 12,279 $3.31 $41K
Feb 11, 2026 GS Gaurav Shah - Officer Grant or award Common Stock 286,028 $0.00 -
Feb 11, 2026 GS Gaurav Shah - Officer Grant or award Stock Option (Right to Buy) 870,648 $0.00 -
$RGNX
REGENXBIO Inc.
$CORT
CORCEPT THERAPEUTICS INC
